BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2021 9:48:20 AM | Browse: 336 | Download: 720
 |
Received |
|
2021-03-02 17:53 |
|
Peer-Review Started |
|
2021-03-02 18:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-17 14:17 |
|
Revised |
|
2021-06-04 02:31 |
|
Second Decision |
|
2021-12-08 07:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-12-10 02:50 |
|
Articles in Press |
|
2021-12-10 02:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-17 04:02 |
|
Publish the Manuscript Online |
|
2021-12-24 09:48 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Emerging therapeutic options in inflammatory bowel disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jesus K Yamamoto-Furusho and Norma N Parra-Holguín |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jesus K Yamamoto-Furusho, MD, MS, PhD, Chief Doctor, Director, Full Professor, Gastroenterology Unit, Inflammatory Bowel Disease Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Vasco de Quiroga 15, Colonia Belisario Domínguez sección XVI, Alcaldía Tlalpan, Mexico City 14080, Mexico. kazuofurusho@hotmail.com |
| Key Words |
Inflammatory bowel disease; Review; Emerging; Treatment; Ulcerative colitis; Crohn´s disease |
| Core Tip |
This review is to present the efficacy and safety of novel treatments for inflammatory bowel disease. The new treatments that may be available in the future are new anti-tumor necrosis factor alpha, anti-integrines, anti-interleukines, modulation of sphingosine-1-phosphate, janus kinase inhibitors, toll like receptor agonist, therapy on the integrity of the epithelial barrier, phosphodiesterase-4 inhibitors and antisense oligonucleotide therapy, currently in clinical studies. Many of them with encouraging results in clinical studies, while others have not been able to maintain significant results in the final phases. |
| Publish Date |
2021-12-24 09:48 |
| Citation |
Yamamoto-Furusho JK, Parra-Holguín NN. Emerging therapeutic options in inflammatory bowel disease. World J Gastroenterol 2021; 27(48): 8242-8261 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i48/8242.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i48.8242 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
